48 related articles for article (PubMed ID: 21320119)
1. A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy.
Fattore C; Boniver C; Capovilla G; Cerminara C; Citterio A; Coppola G; Costa P; Darra F; Vecchi M; Perucca E
Epilepsia; 2011 Apr; 52(4):802-9. PubMed ID: 21320119
[TBL] [Abstract][Full Text] [Related]
2. Comment on "Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution".
Zhang Y; Zhang Q; Zhang J
Pharmacotherapy; 2024 May; 44(5):409-410. PubMed ID: 38853609
[No Abstract] [Full Text] [Related]
3. Response to comment on "Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution".
Price L; Garrity L; Stiehl S
Pharmacotherapy; 2024 May; 44(5):411-412. PubMed ID: 38853603
[No Abstract] [Full Text] [Related]
4. The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study.
Rosenow F; Schade-Brittinger C; Burchardi N; Bauer S; Klein KM; Weber Y; Lerche H; Evers S; Kovac S; Hallmeyer-Elgner S; Winkler G; Springub J; Niedhammer M; Roth E; Eisensehr I; Berrouschot J; Arnold S; Schröder M; Beige A; Oertel WH; Strzelczyk A; Haag A; Reif PS; Hamer HM;
J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1093-8. PubMed ID: 22595362
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of randomized trials on first line and adjunctive levetiracetam.
Lo BW; Kyu HH; Jichici D; Upton AM; Akl EA; Meade MO
Can J Neurol Sci; 2011 May; 38(3):475-86. PubMed ID: 21515509
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of levetiracetam in electrical status epilepticus during sleep of children: a multicenter experience.
Chen XQ; Zhang WN; Yang ZX; Zhao M; Cai FC; Huang SP; Gao L; Pang BD; Chen X; Zou LP
Pediatr Neurol; 2014 Mar; 50(3):243-9. PubMed ID: 24316167
[TBL] [Abstract][Full Text] [Related]
7. The effect of levetiracetam on focal nocturnal epileptiform activity during sleep--a placebo-controlled double-blind cross-over study.
Larsson PG; Bakke KA; Bjørnæs H; Heminghyt E; Rytter E; Brager-Larsen L; Eriksson AS
Epilepsy Behav; 2012 May; 24(1):44-8. PubMed ID: 22494796
[TBL] [Abstract][Full Text] [Related]
8. Effects of levetiracetam monotherapy on the cognitive function of epilepsy patients.
Koo DL; Hwang KJ; Kim D; Kim YJ; Kim JY; Shin W; Kim MR; Joo EY; Lee JM; Hong SB
Eur Neurol; 2013; 70(1-2):88-94. PubMed ID: 23839084
[TBL] [Abstract][Full Text] [Related]
9. Levetiracetam vs. sulthiame in benign epilepsy with centrotemporal spikes in childhood: a double-blinded, randomized, controlled trial (German HEAD Study).
Borggraefe I; Bonfert M; Bast T; Neubauer BA; Schotten KJ; Maßmann K; Noachtar S; Tuxhorn I; May TW; Heinen F;
Eur J Paediatr Neurol; 2013 Sep; 17(5):507-14. PubMed ID: 23642492
[TBL] [Abstract][Full Text] [Related]
10. Subclinical epileptiform activity in children with electrical status epilepticus during sleep: effects on cognition and behavior before and after treatment with levetiracetam.
Bjørnæs H; Bakke KA; Larsson PG; Heminghyt E; Rytter E; Brager-Larsen LM; Eriksson AS
Epilepsy Behav; 2013 Apr; 27(1):40-8. PubMed ID: 23376335
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
Delanty N; Jones J; Tonner F
Epilepsia; 2012 Jan; 53(1):111-9. PubMed ID: 22050371
[TBL] [Abstract][Full Text] [Related]
12. A prehospital randomized trial in convulsive status epilepticus.
Navarro V; Dagron C; Demeret S; An K; Lamhaut L; Bolgert F; Baulac M; Carli P
Epilepsia; 2011 Oct; 52 Suppl 8():48-9. PubMed ID: 21967362
[TBL] [Abstract][Full Text] [Related]
13. A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizures.
Schiemann-Delgado J; Yang H; Loge Cde L; Stalvey TJ; Jones J; Legoff D; Mintz M
J Child Neurol; 2012 Jan; 27(1):80-9. PubMed ID: 21876066
[TBL] [Abstract][Full Text] [Related]
14. Clinical Use and Efficacy of Levetiracetam for Absence Epilepsies.
Nolan D; Lester SG; Rau SM; Shellhaas RA
J Child Neurol; 2019 Feb; 34(2):94-98. PubMed ID: 30458657
[TBL] [Abstract][Full Text] [Related]
15. Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis.
Chu H; Zhang X; Shi J; Zhou Z; Yang X
J Neurol; 2023 Oct; 270(10):4713-4728. PubMed ID: 37378757
[TBL] [Abstract][Full Text] [Related]
16. Interictal epileptiform discharges as a predictive biomarker for recurrence of poststroke epilepsy.
Abe S; Tanaka T; Fukuma K; Matsubara S; Motoyama R; Mizobuchi M; Yoshimura H; Matsuki T; Manabe Y; Suzuki J; Ishiyama H; Tojima M; Kobayashi K; Shimotake A; Nishimura K; Koga M; Toyoda K; Murayama S; Matsumoto R; Takahashi R; Ikeda A; Ihara M;
Brain Commun; 2022; 4(6):fcac312. PubMed ID: 36523270
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of brivaracetam monotherapy in childhood and juvenile absence epilepsy: An innovative adaptive trial design.
Bast T; Schulz AL; Floricel F; Morita D; Cleveland JM; Elshoff JP
Epilepsia Open; 2022 Dec; 7(4):588-597. PubMed ID: 35844134
[TBL] [Abstract][Full Text] [Related]
18. Impact of Antiseizure Medications on Appetite and Weight in Children.
Buraniqi E; Dabaja H; Wirrell EC
Paediatr Drugs; 2022 Jul; 24(4):335-363. PubMed ID: 35596110
[TBL] [Abstract][Full Text] [Related]
19. Current Concepts in the Management of Idiopathic Generalized Epilepsies.
Rathore C; Patel KY; Satishchandra P
Ann Indian Acad Neurol; 2022; 25(1):35-42. PubMed ID: 35342251
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Options for Childhood Absence Epilepsy.
Rinaldi VE; Di Cara G; Mencaroni E; Verrotti A
Pediatr Rep; 2021 Dec; 13(4):658-667. PubMed ID: 34941639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
